![](/img/cover-not-exists.png)
DOP40 Effectiveness and safety of reference infliximab and biosimilar in Crohn’s disease: a French equivalence study
Meyer, A, Rudant, J, Drouin, J, Weill, A, Carbonnel, F, Coste, JVolume:
13
Journal:
Journal of Crohn's and Colitis
DOI:
10.1093/ecco-jcc/jjy222.074
Date:
January, 2019
File:
PDF, 84 KB
2019